201620172018201920202021202220232024Billable/Specific Code
- Z79.4 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM Z79.4 became effective on October 1, 2022.
- This is the American ICD-10-CM version of Z79.4 – other international versions of ICD-10 Z79.4 may differ.
Type 2 Excludes
- long-term (current) use of injectable non-insulin antidiabetic drugs (Z79.85)
- long term (current) use of oral antidiabetic drugs (Z79.84)
- long term (current) use of oral hypoglycemic drugs (Z79.84)
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change